Metrics as of 10/14/2026, 08:40 AM (Berlin time), refresh in progress.
Microbix Biosystems Inc.
Microbix Biosystems Inc. is a life science enterprise dedicated to advancing human health globally, including markets across North America and Europe. Established in 1988 and headquartered in Mississauga, Canada, the company specializes in developing and marketing unique biological and technological products. A…
1D
-3.2%
1W
+0.0%
1M
-3.2%
6M
+22.4%
YTD
+30.4%
1Y
+11.1%
2Y
-10.4%
5Y
-53.1%
10Y
+30.4%
Next earnings date
17/12/2026 (in 61 days)
Volatility around earnings
~11% weaker price swings than usual
P/E
-8.5
P/B
1.66
EV/EBITDA
-17.74
RETURN ON EQUITY
-3.3%
NET MARGIN
-19.9%
DEBT/EQUITY
0.28
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
83.6%
FLOAT SHARES
114,957,717
AVG. DAILY VOLUME (30D)
22,658
Microbix Biosystems Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in Canada.
The CEO is Cameron L. Groome, the company employs around 100 people.
The IPO was on 13/08/1996; the stock trades on TSX under the ticker MBX.TO.
The next earnings date is 17/12/2026.
Around past earnings, price swings were roughly -11% stronger than usual.
Yes. The last dividend was CA$0.28 per share.
The dividend yield is 0.0% (as of 30/06/2026).
Comparable stocks include AbCellera Biologics, Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines and Incyte.
Clicking "Analyze stock" lets five strategies assess Microbix Biosystems against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.